Back
Freenome, Inc. FRNM · Insights
Freenome is an early cancer detection company developing blood-based screening tests to identify can... Price10.57
Market Cap1.14 B
Float58.16 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro